Sleep apnea in patients with chronic heart failure - Pathophysiology, diagnosis and treatment;Schlafapnoe: Bedeutung bei patienten mit herzinsuffizienz - Pathophysiologie, diagnostik und therapie

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 9, 2005, Pages 468-472

  Steiner, S ^a,c   Schwartzkopff, B ^a   Strauer, B E ^a   Schultze Werninghaus, G ^b   Duchna, H W ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEYNE STOKES BREATHING; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGICAL DATA; HEART FAILURE; HUMAN; HYPERVENTILATION SYNDROME; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; TREATMENT INDICATION;

AIRWAY OBSTRUCTION; HEART FAILURE, CONGESTIVE; HUMANS; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 14844293060     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-863079     Document Type: Review

References (58)

1. American Sleep Disorders Association. Practice parameters for the treatment of snoring and obstructive sleep apnea. Sleep 1995; 18: 511-513
2. Andreas S, Clemens C, Sandholzer H, Figulla H, Kreuzer H. Improvement of exercise capacity with the treatment of cheyne-stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27: 1486-1490
3. Andreas S, Hagenah G, Möller C, Werner G, Kreuzer H. Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol 1996; 78: 1260-1264
4. Arzt M, Harth M, Luchner A et al. Enhanced ventilatory responses to exercise in patients with chronic heart failure and central sleep apnea. Circulation 2003; 107: 1998-2003
5. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73
6. Bradley TD, Floras JS. Sleep apnea and heart failure. Part 1: obstructive sleep apnea. Circulation 2003; 107: 1671-1678
7. Bradley TD. Logan AG, Floras JS. Rationale and design of the Canadian continuous positive airway pressure trial for congestive heart failure patients with central sleep apnea. Can J Cardiol 2001; 17: 677-684
8. Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnea/hypopnea syndrome. Lancet 1994; 344: 653-655
9. Duchna H-W, Guilleminault C, Stoohs RA et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000; 161: 187-191
10. Duchna H-W, Guilleminault C, Stoohs RA, Orth M et al. Das obstruktive Schlafapnoe-Syndrom: Ein kardiovaskulärer Risikofaktor? Z Kardiol 2001; 90: 568-575
11. Duchna H-W, Grote L, Andreas S et al. State of the art article: Sleep-disordered breathing and cardio- and cerebrovascular diseases: update 2003 of clinical significance and future perspectives. Somnologie 2003; 7: 101-121
12. Dunai J, Kleiman J, Trinder J. Ventilatory instability during sleep onset in individuals with high peripheral chemosensitivity. J Appl Physiol 1999; 87: 661-672
13. Fischer J. Schlafbezogene Atmungsstörungen (Apnoe-Syndrom). Auflage 1 (Hrsg). Deisenhofen: Dustri-Verlag, In: Nolte D, editor. Manuale Pneumologicum. 1992: 1-19
14. Freimark D, Adler Y, Sheffy J et al. Oscillations in peripheral arterial tone in congestive heart failure patients: a new marker for Cheyne-Stokes breathing. Cardiology 2002; 98: 21-24
15. Guilleminault C. Clinical features and evaluation of obstructive sleep apnea. W.B. Saunders Company, London, Toronto, montreal, Sydney, Tokyo, In: Kryger MH, Roth T, Dement WC, editors: Principles and practice of sleep medicine. 1994: 667-677
16. Hanley P, Zuberi N, Gray R. Pathogenesis of cheyne-stokes respiration in patients with congestive heart failure. Relationship to PCO2. Chest 1999; 104: 1079-1084
17. Hoppe UC, Erdmann E. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 2001; 90: 218-237
18. Jahaveri S, Corbett W. Association of low PaO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 1998; 128: 204-297
19. Javaheri S, Parker TJ, Liming J et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-2159
20. Javerheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 1999; 341: 949-954
21. Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-1241
22. Kelm M, Strauer BE. Endotheliale Dysfunktion - Therapeutische und prognostische Relevanz. Internist 1999; 40: 1300-1307
23. Lanfranchi P, Braghioli A, Bosimini E et al. Prognostic value of nocturnal cheyne -stokes respiration in chronic heart failure. Circulation 1999; 99: 1435-1440
24. Lanfranchi P, Somers V, Braghiroli A et al. Central sleep apnea in left ventricular dysfunction. Prevalence and implications for arrythmic risk. Circulation 2003; 107: 727-732
25. Levy D, Kenchaiah S, Larson MG et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402
26. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation 2002; 105: 1135-1143
27. Lipkin D. Sleep disordered breating in chronic stable heart failure. Lancet 1999; 354: 531-532
28. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-366
29. Mansfield D, Kaye D, Brunner LRH, Solin P, Esler M, Naughton M. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003; 107: 1396-1400
30. Marti S, Sampol G, Munoz X et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-1518
31. Metha S, Liu P, Fitzgerald F, Allinda Y, Bradley T. Effects of continuous positive airway pressure on cardiac volumes in patients with ischemic and dilated cardiomyopathy. Am J Respir Crit Care Med 2000; 161: 128-134
32. Narkiewicz K, van de Borne P, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98: 772-776
33. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100: 2332-2335
34. Naughton MT, Benard D, Liu P, Rutherford R. Rankin F, Bradley D. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152: 473-479
35. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA. Sleep apnea and markers of vascular endothelial dysfunction in a large community sample of older adults. Am J Respir Crit Care Med 2004; 169: 354-360
36. Orth M, Rasche K, Duchna H-W. Konservative Therapie. Blackwell, Berlin, Wien, In: Rasche K, Sanner B, Schäfer T, Schläfke ME, Sturm A, Zidek W (HRSG): Schlafbezogene Atmungsstörungen in Klinik und Praxis. 1999: 212-221
37. Peperell JC, Ramdassingh-Dow S, Crosthwaite N et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2001; 359: 204-210
38. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384
39. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future - report of a workshop from the national center on sleep disorders research and the national heart, lung, and blood institute. Circulation 2004; 109: 951-957
40. Sanner B, Hader C, Rasche K. Das obstruktive Schlafapnoe-Syndrom - Therapie. Dtsch Med Wochenschr 2004; 129: 570-572
41. Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, MennS. Oral applicances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18: 501-510
42. Schulz R, Schmidt D, Blum A et al. Decreased plasma levels of nitric oxide derivates in obstructive sleep apnea: response to CPAP-Therapy. Thorax 2000; 55: 1046-1051
43. Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease - Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25
44. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290: 1906-1914
45. Sin D, Fitzgerald F, Parker JD et al. Relationship of systolic BP to obstructive sleep apnea in patients with heart failure. Chest 2003; 123: 1536-1543
46. Sin D, Logan A, Fitzgerald F, Liu P, Bradley T. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without cheyne-stokes respiration. Circulation 2000; 102: 61-66
47. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 2002; 121: 164-172
48. Solin P, Bergin P, Richardson M, Kaye D, Walters E, Naughton M. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999; 99: 1574-1579
49. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904
50. Steiner S, Perings C. Pulmonalarterielle Hypertonie und Cor pulmonale bei obstruktiver Schlafapnoe: Pathophysiologie und klinische Relevanz. Internist 1999; 40: 739-746
51. Steiner S, Schwalen A, Strauer BE. Kardiologische Diagnostik bei Patienten mit obstruktiver Schlafapnoe. Dtsch Med Wochenschr 2002; 38: 1958-1962
52. Teschler H, Dohring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001; 164: 614-619
53. Thalhofer SA, Kiwus U, Dorow P. Influence of orthotopic heart transplantation on breathing pattern disorders in patients with dilated cardiomyopathy. Sleep Breath 2000; 4: 121-126
54. Tremel F, Pepin JL, Veale D et al. High prevalence and persistance of sleep apnea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999; 20: 1201-1209
55. Trinder J, Merson R, Rosenberg JI, Fitzgerald F, Kleiman J, Bradley DT. Pathophysiological interactions of ventilation, arousals, and blood pressure oscillations during cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 2000; 162: 808-813
56. Yokoe T, Minoguchi K, Matsuo H et al. Elevated Levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134
57. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993; 328: 1230-1235
58. Hader C, Sanner B, Rasche K. Das obstruktive Schlafapnoe-Syndrom - Diagnostik. Dtsch Med Wochenschr 2004; 129: 566-569